Carcinoma
Showing 26 - 50 of >10,000
Hepatocellular Carcinoma Trial in Wuhan (Sintilimab, Transarterial Chemoembolization (TACE))
Not yet recruiting
- Hepatocellular Carcinoma
- Sintilimab
- Transarterial Chemoembolization (TACE)
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Oct 17, 2023
Moesin Expression in Clear Cell Renal Cell Carcinoma
Completed
- Renal Cell Carcinoma
- Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
- (no location specified)
Sep 20, 2023
Hepatocellular Carcinoma Trial in Mansoura (Sorafenib Tablets)
Recruiting
- Hepatocellular Carcinoma
- Sorafenib Tablets
-
Mansoura, El-Dakahelia, EgyptMansoura University Hospital
Sep 3, 2023
Nasopharyngeal Carcinoma by AJCC V8 Stage Trial (New-mode reduce-volume target IMRT)
Not yet recruiting
- Nasopharyngeal Carcinoma by AJCC V8 Stage
- New-mode reduce-volume target IMRT
- (no location specified)
Oct 18, 2023
Cell Carcinoma Trial in Nice (Tirbanibulin)
Not yet recruiting
- Cell Carcinoma
-
Nice, Alpes-maritimes, FranceCHU de Nice - Hôpital de l'Archet
Oct 27, 2023
Pure Florid and Pleomorphic Lobular Carcinoma in Situ of Breast:
Recruiting
- Pleomorphic Lobular Breast Carcinoma in Situ
- Breast Florid Lobular Carcinoma in Situ
- Surgical wide local excision
- +4 more
-
Padova, ItalyIstituto Oncologico Veneto IRCCS
Nov 14, 2023
Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)
Not yet recruiting
- Merkel Cell Carcinoma
- Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
-
Wollstonecraft, New South Wales, AustraliaMelanoma Institute Australia
Nov 21, 2023
Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, Tislelizumab Combined with RALOX Regimen HAIC)
Recruiting
- Hepatocellular Carcinoma
- Lenvatinib, Tislelizumab Combined with RALOX Regimen HAIC
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Jul 12, 2023
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity
Not yet recruiting
- Nasopharyngeal Carcinoma
-
Fuzhou, Fujian, ChinaDepartment of radiation oncology, Fujian cancer hospital
Nov 16, 2023
Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Carrilizumab, bevacizumab,capecitabine
- (no location specified)
Jul 20, 2023
Gastrointestinal Neuroendocrine Carcinoma Trial in Beijing (Durvalumab and Chemotherapy(oxaliplatin and capecitabine))
Recruiting
- Gastrointestinal Neuroendocrine Carcinoma
- Durvalumab and Chemotherapy(oxaliplatin and capecitabine)
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 1, 2023
Nasopharyngeal Carcinoma Screening Based on Tongue Imaging
Not yet recruiting
- Nasopharyngeal Carcinoma
- Tongue image
-
Zhuhai, ChinaThe Fifth Affiliated Hospital of Sun Yat sen University
Nov 10, 2023
Squamous Cell Carcinoma of Head and Neck, Basal Cell Carcinoma of Skin Trial in Vandœuvre-lès-Nancy (microscopy confocal
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- Basal Cell Carcinoma of Skin
- microscopy confocal (Histolog Scanner)
-
Vandœuvre-lès-Nancy, FranceGilles Dolivet
Jul 7, 2023
Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])
Not yet recruiting
- Neoplasms
- +2 more
- Nivolumab Injection [Opdivo]
- (no location specified)
Jul 19, 2023
Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer Trial (EYE90 Microspheres Treatment)
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- EYE90 Microspheres Treatment
- (no location specified)
Jul 12, 2023
Hepatocellular Carcinoma Trial in Hangzhou (Fruquintinib, Sintilimab, Transcatheter arterial chemoembolization(TACE))
Recruiting
- Hepatocellular Carcinoma
- Fruquintinib
- +2 more
-
Hangzhou, Zhejiang, ChinaGuoliang Shao
Aug 1, 2023
Cutaneous Squamous Cell Carcinoma Trial (INCB099280)
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- (no location specified)
May 24, 2023
Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
- (no location specified)
Aug 17, 2023
Hepatocellular Carcinoma Trial in Seoul (Microwave ablation)
Recruiting
- Hepatocellular Carcinoma
- Microwave ablation
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 10, 2023
Hepatocellular Carcinoma, Liver Cancer Trial in Seoul (IDA-TACE, DOX-TACE)
Recruiting
- Hepatocellular Carcinoma
- Liver Cancer
- IDA-TACE
- DOX-TACE
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 27, 2023
Esophageal Carcinoma Trial (Immune Checkpoint Inhibitors)
Not yet recruiting
- Esophageal Carcinoma
- Immune Checkpoint Inhibitors
- (no location specified)
Jul 6, 2023
Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma
Recruiting
- Head and Neck Squamous Cell Carcinoma
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Aug 22, 2023